NVST Envista Holdings Corporation
$25.55▼ -1.24%
Healthcare
Other
After hours
$25.55▲ +0.00%
Sep 11, 4:50 PM ET
Volume 3.99M
Avg Volume (10D) 1.87M
Key Metrics & Fundamentals
Market Cap
$4.10B
P/E Ratio
44.1
Div Yield
–%
52W Range
18.77 - 30.42
% vs 50 MA
-5.93%
% vs 200 MA
0.45%
RSI-14
35.0
MACD Histogram
-0.2200
Beta (1Y vs SPY)
1.26
Free Cash Flow
$104.30M
Gross Rev
$730.50M
Gross Profit
$407.00M
EBITDA
$120.30M
COGS
$323.50M
Operating Exp
$326.70M
Operating Income
$80.30M
EBIT
$80.30M
Pretax Income
$74.40M
Net Income
$53.70M
EPS (Diluted)
0.33
Price & Volume History
Loading chart…
Recent News
NVST or ABT: Which Is the Better Value Stock Right Now?
Zacks · Sep 9, 2026 3:40 PM
Envista Announces Participation in Baird 2026 Global Healthcare Conference
PR Newswire · Sep 8, 2026 8:10 PM
XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure
Zacks · Sep 8, 2026 4:13 PM
Envista (NVST) Up 0.8% Since Last Earnings Report: Can It Continue?
Zacks · Sep 4, 2026 3:30 PM
1 Stock Under $50 Worth Your Attention and 2 Facing Challenges
StockStory · Sep 4, 2026 12:14 PM
Envista Holdings Shares Rise After JPMorgan Upgrade
InvestorsHub · Sep 3, 2026 1:45 PM
Broadcom upgraded, Ultragenyx downgraded: Wall Street's top analyst calls
The Fly · Sep 3, 2026 1:31 PM
Here Are Thursday’s Top Wall Street Analyst Research Calls: Broadcom, Deere & Company, Dell Technologies, Devon Energy, Moderna, Permian Resources, PG&E, Thermo Fisher, Viper Energy, and More
24/7 Wall St. · Sep 3, 2026 12:05 PM
JPMorgan Upgrades Envista to Overweight From Neutral, Lifts Price Target to $32 From $29
MT Newswires · Sep 3, 2026 11:11 AM
1 Small-Cap Stock on Our Buy List and 2 We Brush Off
StockStory · Sep 2, 2026 11:56 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See NVST's money flow as a full page
Social Sentiment
Avg +0.60 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.